{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:13:21Z","timestamp":1782422001955,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["GW190010"],"award-info":[{"award-number":["GW190010"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["R01EY026174"],"award-info":[{"award-number":["R01EY026174"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026174"],"award-info":[{"award-number":["R01EY026174"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ajoc.2020.100809","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T18:37:06Z","timestamp":1593887826000},"page":"100809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: Case series of four patients"],"prefix":"10.1016","volume":"19","author":[{"given":"Nandini","family":"Venkateswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Diel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy C.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos D.","family":"Sarantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7624-777X","authenticated-orcid":false,"given":"Wendy W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2020.100809_bib1","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1167\/iovs.12-10819","article-title":"Ocular surface parameters in older male veterans","volume":"54","author":"Galor","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100809_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1542-0124(12)70290-2","article-title":"Corneal pain without stain: is it real?","volume":"7","author":"Rosenthal","year":"2009","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100809_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.ajoc.2020.100809_bib4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bjophthalmol-2016-309658","article-title":"Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain","volume":"101","author":"Crane","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100809_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.ajoc.2020.100809_bib6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100809_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2015.01.005","article-title":"Autologous serum tears for treatment of photoallodynia in patients with corneal neuropathy: efficacy and evaluation with in vivo confocal microscopy","volume":"13","author":"Aggarwal","year":"2015","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100809_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/ICL.0000000000000630","article-title":"Oral gabapentinoids and nerve blocks for the treatment of chronic ocular pain","volume":"46","author":"Small","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100809_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/ner.12742","article-title":"Noninvasive electrical stimulation for the treatment of chronic ocular pain and photophobia","volume":"21","author":"Sivanesan","year":"2018","journal-title":"Neuromodulation"},{"key":"10.1016\/j.ajoc.2020.100809_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/ner.13146","article-title":"Transcutaneous electrical nerve stimulation for the long-term treatment of ocular pain","author":"Zayan","year":"2020","journal-title":"Neuromodulation"},{"key":"10.1016\/j.ajoc.2020.100809_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajoc.2019.02.001","article-title":"Resolution of pain with periocular injections in a patient with a 7-year history of chronic ocular pain","volume":"14","author":"Duerr","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2020.100809_bib12","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2147\/JPR.S168650","article-title":"Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2018","journal-title":"J Pain Res"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100809_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0036-1571953","article-title":"Botulinum toxin treatment of neuropathic pain","volume":"36","author":"Mittal","year":"2016","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100809_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.survophthal.2016.02.001","article-title":"Diagnosis, pathophysiology, and treatment of photophobia","volume":"61","author":"Katz","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100809_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2017.09.031","article-title":"Botulinum toxin A for the treatment of photophobia and dry eye","volume":"125","author":"Diel","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100809_bib16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bjophthalmol-2018-312649","article-title":"Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections","volume":"103","author":"Diel","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100809_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.6.4.18","article-title":"New methods for quantification of visual photosensitivity threshold and symptoms","volume":"6","author":"Verriotto","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100809_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"issue":"4259","key":"10.1016\/j.ajoc.2020.100809_bib19","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1126\/science.785600","article-title":"Botulinum toxin: mechanism of presynaptic blockade","volume":"193","author":"Kao","year":"1976","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100809_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ajoc.2020.100809_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2013.02.006","article-title":"Botulinum toxins: mechanisms of action, antinociception and clinical applications","volume":"306","author":"Wheeler","year":"2013","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100809_bib22","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","article-title":"Botulinum toxin for neuropathic pain: a review of the literature","volume":"7","author":"Oh","year":"2015","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100809_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100809_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2006.02.035","article-title":"Peripheral and central distribution of TRPV1, substance P and CGRP of rat corneal neurons","volume":"1085","author":"Murata","year":"2006","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.ajoc.2020.100809_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100809_bib26","first-page":"269","article-title":"Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature","volume":"8","author":"Jeynes","year":"2008","journal-title":"Pain Pract Off J World Inst Pain"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2020.100809_bib30","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","article-title":"Evidence for antinociceptive activity of botulinum toxin type A in pain management","volume":"43","author":"Aoki","year":"2003","journal-title":"Headache"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2020.100809_bib31","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2011.06.013","article-title":"Updates on the antinociceptive mechanism hypothesis of botulinum toxin A","volume":"17","author":"Aoki","year":"2011","journal-title":"Park Relat Disord"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100809_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11916-016-0578-4","article-title":"Diverse physiological roles of calcitonin gene-related peptide in migraine pathology: modulation of neuronal-glial-immune cells to promote peripheral and central sensitization","volume":"20","author":"Durham","year":"2016","journal-title":"Curr Pain Headache Rep"},{"issue":"44","key":"10.1016\/j.ajoc.2020.100809_bib33","doi-asserted-by":"crossref","first-page":"15439","DOI":"10.1523\/JNEUROSCI.3265-12.2012","article-title":"Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B\/D) agonist","volume":"32","author":"Kaiser","year":"2012","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"27","key":"10.1016\/j.ajoc.2020.100809_bib34","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1523\/JNEUROSCI.1727-09.2009","article-title":"Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine","volume":"29","author":"Recober","year":"2009","journal-title":"J Neurosci : Off J Soc Neurosci"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100809_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.exer.2003.09.023","article-title":"Neural basis of sensation in intact and injured corneas","volume":"78","author":"Belmonte","year":"2004","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajoc.2020.100809_bib36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pain.2010.02.022","article-title":"Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner","volume":"149","author":"Dessem","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100809_bib37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.pain.2010.07.029","article-title":"Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis","volume":"151","author":"Gazerani","year":"2010","journal-title":"Pain"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620301420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620301420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:54:33Z","timestamp":1778889273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993620301420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"alternative-id":["S2451993620301420"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100809","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: Case series of four patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100809"}}